Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

1737 ARTÍCULOS , VIENDO DEL 1381 AL 1395

Restless legs syndrome secondary to sacral zona zoster

Ipekdal IH, Karadas O, Oz O, Ulas UH.

J Pain Symptom Manage. 2011 Apr;41(4):e8-11. doi: 10.1016/j.jpainsymman.2010.11.007. Epub 2011 Feb 3.

Sleep problems in midlife and beyond

Polo-Kantola P.

Maturitas. 2011 Mar;68(3):224-32. doi: 10.1016/j.maturitas.2010.12.009. Epub 2011 Feb 3.

Mirtazapine-induced worsening of restless legs syndrome (RLS) and ropinirole-induced psychosis: challenges in management of depression in RLS

Chopra A, Pendergrass DS, Bostwick JM.

Psychosomatics. 2011 Jan-Feb;52(1):92-4. doi: 10.1016/j.psym.2010.11.009.

Systemic lupus and risk of restless legs syndrome

Hassan N, Pineau CA, Clarke AE, Vinet E, Ng R, Bernatsky S.

J Rheumatol. 2011 May;38(5):874-6. doi: 10.3899/jrheum.101039. Epub 2011 Feb 15.

Levodopa for restless legs syndrome

Scholz H, Trenkwalder C, Kohnen R, Riemann D, Kriston L, Hornyak M.

Cochrane Database Syst Rev. 2011 Feb 16;2011(2):CD005504. doi: 10.1002/14651858.CD005504.pub2.

Evaluation of sleep disorders in the primary care setting: history taking compared to questionnaires

Senthilvel E, Auckley D, Dasarathy J.

J Clin Sleep Med. 2011 Feb 15;7(1):41-8.

Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndrome

Högl B, Garcia-Borreguero D, Trenkwalder C, Ferini-Strambi L, Hening W, Poewe W, Brenner SS, Fraessdorf M, Busse M, Albrecht S, Allen RP.

Sleep Med. 2011 Apr;12(4):351-60. doi: 10.1016/j.sleep.2010.12.007. Epub 2011 Feb 26.

Pramipexole versus ropinirole: polysomnographic acute effects in restless legs syndrome

Manconi M, Ferri R, Zucconi M, Oldani A, Giarolli L, Bottasini V, Ferini-Strambi L.

Mov Disord. 2011 Apr;26(5):892-5. doi: 10.1002/mds.23543. Epub 2011 Mar 2.

Sexual intercourse and masturbation: potential relief factors for restless legs syndrome?

Marin LF, Felicio AC, Prado GF.

Sleep Med. 2011 Apr;12(4):422. doi: 10.1016/j.sleep.2011.01.001. Epub 2011 Mar 4.

Dopamine agonists for restless legs syndrome

Scholz H, Trenkwalder C, Kohnen R, Riemann D, Kriston L, Hornyak M.

Cochrane Database Syst Rev. 2011 Mar 16;2011(3):CD006009. doi: 10.1002/14651858.CD006009.pub2.

Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances

Jaber BL, Schiller B, Burkart JM, Daoui R, Kraus MA, Lee Y, Miller BW, Teitelbaum I, Williams AW, Finkelstein FO; FREEDOM Study Group.

Clin J Am Soc Nephrol. 2011 May;6(5):1049-56. doi: 10.2215/CJN.10451110. Epub 2011 Mar 17.

L-Dopa improves Restless Legs Syndrome and periodic limb movements in sleep but not Attention-Deficit-Hyperactivity Disorder in a double-blind trial in children

England SJ, Picchietti DL, Couvadelli BV, Fisher BC, Siddiqui F, Wagner ML, Hening WA, Lewin D, Winnie G, Cohen B, Walters AS.

Sleep Med. 2011 May;12(5):471-7. doi: 10.1016/j.sleep.2011.01.008. Epub 2011 Apr 3.

Genome-wide association study of motor coordination problems in ADHD identifies genes for brain and muscle function

Fliers EA, Vasquez AA, Poelmans G, Rommelse N, Altink M, Buschgens C, Asherson P, Banaschewski T, Ebstein R, Gill M, Miranda A, Mulas F, Oades RD, Roeyers H, Rothenberger A, Sergeant J, Sonuga-Barke E, Steinhausen HC, Faraone SV, Buitelaar JK, Franke B.

World J Biol Psychiatry. 2012 Mar;13(3):211-22. doi: 10.3109/15622975.2011.560279. Epub 2011 Apr 7.

Restless legs syndrome in children: a review and update on pharmacological options

Frenette E.

Curr Pharm Des. 2011;17(15):1436-42. doi: 10.2174/138161211796197142.

Dopaminergic augmentation of restless legs syndrome: the scope of the problem

García-Borreguero D, Williams AM.

Sleep Med. 2011 May;12(5):425-6. doi: 10.1016/j.sleep.2011.03.004. Epub 2011 Apr 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias